Differential effects of chronic drug treatment on α3* and α7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells

British Journal of Pharmacology

Volumn 133, Issue 8, 2001, Pages 1286-1295

  Ridley, Diana L ^a   Rogers, Adrian ^a   Wonnacott, Susan ^a  

^a University of Bath   (United Kingdom)

Author keywords

CaM kinase II; DMAC; KCl depolarization; Nicotine; Nicotinic receptor; Primary hippocampal cultures; SH SY5Y cells; Upregulation

Indexed keywords

BUNGAROTOXIN; CHOLINERGIC RECEPTOR; EPIBATIDINE; IODINE 125; MALEIC ACID; METHYLLYCACONITINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; POTASSIUM CHLORIDE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; TRITIUM; TUBOCURARINE CHLORIDE; VERAPAMIL;

ARTICLE; BINDING SITE; CELL POPULATION; CONTROLLED STUDY; DEPOLARIZATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

ALKALOIDS; ANIMALS; AZOCINES; BACTERIAL TOXINS; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; BUNGAROTOXINS; CELLS, CULTURED; DIMETHYLPHENYLPIPERAZINIUM IODIDE; HIPPOCAMPUS; HUMANS; INHIBITORY CONCENTRATION 50; MARINE TOXINS; MICROCYSTINS; NEUROBLASTOMA; NEURONS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PYRIDINES; QUINOLIZINES; RATS; RECEPTORS, NICOTINIC; TUBOCURARINE; TUMOR CELLS, CULTURED; UP-REGULATION; VERAPAMIL;

EID: 0034871936     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704207     Document Type: Article

References (43)

1. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes
2. α-Bungarotoxin binding sites in rat hippocampal and cortical cultures: Initial characterisation, colocalisation with α7 subunits and upregulation by chronic nicotine treatment
3. Mechanisms of upregulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain
4. 3H]-nicotine binding sites in human brain
5. 3H]-nicotine binding in human postmortem brain
6. 50) of an enzymatic reaction
7. 3H]methylycaconitine: A new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors
8. 125I-α-bungarotoxin receptor subtypes
9. Differential regulation of neuronal nicotinic ACh receptor subunit genes in cultured neonatal rat sympathetic neurones: Specific induction of α7 by membrane depolarisation through a calcium/calmodulin-dependent kinase pathway
10. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment
11. Calcium signalling in neurons: Molecular mechanisms and cellular consequences
12. Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways
13. Calcium regulation of immediate early gene transcription
14. Evidence that nicotinic α7 receptors are not involved in the hyperlocomotor and rewarding effects of nicotine
15. A novel nicotinic agonist facilitates induction of long term potentiation in the rat hippocampus
16. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment
17. Characterisation of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line
18. Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems
19. Long term potentiation of excitatory inputs to brain reward areas by nicotine
20. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
21. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
22. Upregulation of human α7 nicotinic receptors by chronic treatment with activator and antagonist ligands
23. Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents
24. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment
25. Chronic nicotine up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y
26. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover
27. Human α7 acetylcholine receptor: Cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 hopmomers expressed in Xenopus oocytes
28. Similarity between rat brain nicotinic α-bungarotoxin receptors and stably expressed α-bungarotoxin binding sites
29. Marked upregulation of the αbungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists
30. Modulation of α7- and α3containing nicotinic receptor expression in SH-SY5Y cells and primary hippocampal neurones
31. Differential upregulation of α7 and α3 subunit-containing nicotinic acetylcholine receptors in rat hippocampal and PCI2 cell cultures
32. Nicotinic receptors in the development and modulation of CNS synapses
33. Dose-response relationship for nicotine-induced upregulation of rat brain nicotinic receptors
34. Molecular cloning, functional properties and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium
35. UB-165: A novel nicotinic agonist with subtype selectivity implicates the α4β2* subtype in the modulation of dopamine release from rat striatal synaptosomes
36. KN-62, l-IN, O-Bis(5isoquinolinesulfonyl)-N-methyl L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of calcium/calmodulin-dependent protein kinase II
37. Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y
38. Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2 and β4 subunits
39. Chronic nicotine treatment up-regulates human α3β2 but not α3β4 acetylcholine receptors stably transfected in human embryonic kidney cells
40. Agonist induced upregulation of α4β2 nicotinic acetylcholine receptors in M10 cells: Pharmacological and spatial definition
41. The paradox of nicotinic acetylcholine receptor upregulation by nicotine
42. Regulation of α4β2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agonists
43. Identification of four classes of brain nicotinic receptors using β2 mutant mice